Griseofulvin
Overview
Griseofulvin is antifungal agent produced by Pencillium griseofulvum. It acts as a fungistatic. It has been largely replaced by a newer antifungal medications such as itraconazole and terbinafine.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Griseofulvin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 500 to 1000 mg | 750 (750) | 24 hourly | PO | |
Paedriatic Dosage (20kg)
|
| 10 mg/kg | 10 (10) | 24 hourly | Oral | - |
Neonatal Dosage (3kg)
|
| 10 mg/kg | 10 (10) | 24 hourly | Oral | |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Vidarabine (Monohydrate)
Back to top
Previous Drug Generic - Next Drug Generic